WEST PHARMACEUTICAL SERVICES INC financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
WST on NYSE
Location
Exton, PA
Fiscal year end
31 December
Latest financial report
17 Feb 2026

Quick Takeaways

  • WST - WEST PHARMACEUTICAL SERVICES INC financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 17%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-4.8%</span>.
  • Most recent SEC facts end date: 29 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-01-29) highlights Return On Equity 16.9%, Return On Assets 10.1%, and Operating Margin 21.6%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

68.1/100

Balanced Confidence high

Return On Equity

17%

Metric score 52.1/100

Return On Assets

10%

Metric score 100.0/100

Financial Health

Current Ratio
3.02x
Quick Ratio
2.1x
Debt to Equity
0.1x

Strengths

Return On Assets, Operating Margin, and Quick Ratio

Watchpoints

NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

17%

YoY: -4.8%

Industry median: -17% (n=179)

View history

Return On Assets

10%

YoY: -5.4%

Industry median: -34% (n=178)

View history

Operating Margin

22%

YoY: -3.4%

Industry median: -18% (n=127)

View history

Current Ratio

3.02x

YoY: +8.1%

Industry median: 2.36x (n=176)

View history

Quick Ratio

2.1x

YoY: +11%

Industry median: 1.49x (n=146)

View history

Debt-to-equity

0.1x

YoY: -0.26%

Industry median: 0.46x (n=133)

View history

Revenues YoY

6.3%

YoY:

Industry median: 15% (n=128)

View history

NetIncomeLoss YoY

0.2%

YoY:

Industry median: 0.49% (n=168)

View history

Profitability

Metric Latest value YoY change
Return On Equity 17% -4.8%
Return On Assets 10% -5.4%
Operating Margin 22% -3.4%

Financial Health

Metric Latest value YoY change
Current Ratio 3.02x +8.1%
Quick Ratio 2.1x +11%
Debt-to-equity 0.1x -0.26%

Growth

Metric Latest value YoY change
Revenues YoY 6.3%
NetIncomeLoss YoY 0.2%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 72,021,491 -0.39%
Common Stock, Shares, Outstanding 72,000,000 -0.42%
Common Stock, Value, Issued $18,800,000 0%
Weighted Average Number of Shares Outstanding, Basic 72,300,000 -0.96%
Weighted Average Number of Shares Outstanding, Diluted 72,700,000 -1.4%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $3,074,100,000 +6.3%
Research and Development Expense $74,300,000 +7.5%
Operating Income (Loss) $584,900,000 +2.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $600,900,000 +2.6%
Income Tax Expense (Benefit) $121,600,000 +13%
Earnings Per Share, Basic 6.83 +1.2%
Earnings Per Share, Diluted 6.79 +1.5%
Cash and Cash Equivalents, at Carrying Value $791,300,000 +63%
Accounts Receivable, after Allowance for Credit Loss, Current $574,400,000 +4%
Inventory, Net $443,900,000 +18%
Other Assets, Current $168,600,000 +36%
Assets, Current $1,978,200,000 +29%
Deferred Income Tax Assets, Net $38,400,000 +48%
Property, Plant and Equipment, Net $1,726,400,000 +9.2%
Operating Lease, Right-of-Use Asset $117,000,000 +12%
Intangible Assets, Net (Excluding Goodwill) $7,700,000 -29%
Goodwill $109,900,000 +3.7%
Other Assets, Noncurrent $80,100,000 +7.8%
Assets $4,270,000,000 +17%
Accounts Payable, Current $253,700,000 +6%
Liabilities, Current $654,900,000 +19%
Deferred Income Tax Liabilities, Net $23,000,000 +12%
Operating Lease, Liability, Noncurrent $95,600,000 +17%
Other Liabilities, Noncurrent $75,200,000 +21%
Liabilities $1,094,000,000 +14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $105,500,000 +59%
Retained Earnings (Accumulated Deficit) $4,374,900,000 +11%
Stockholders' Equity Attributable to Parent $3,176,000,000 +18%
Liabilities and Equity $4,270,000,000 +17%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 75,300,000 0%
Common Stock, Par or Stated Value Per Share 0.25 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $791,300,000 +63%
Deferred Tax Assets, Valuation Allowance $16,200,000 +27%
Operating Lease, Liability $118,300,000 +19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $646,300,000 +71%
Lessee, Operating Lease, Liability, to be Paid $146,400,000 +29%
Property, Plant and Equipment, Gross $3,223,400,000 +8%
Operating Lease, Liability, Current $22,700,000 +27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,000,000 +1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $27,400,000 +17%
Operating Lease, Weighted Average Discount Rate, Percent 0.0467 +17%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28,100,000 +110%
Lessee, Operating Lease, Liability, to be Paid, Year Three $20,100,000 +23%
Deferred Tax Assets, Operating Loss Carryforwards $3,200,000 -48%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 3,000,000 0%
Unrecognized Tax Benefits $56,100,000 +29%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,800,000 -0.67%
Additional Paid in Capital $0 -100%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $171,400,000 +10%
Deferred Tax Assets, Net of Valuation Allowance $114,100,000 +22%
Share-based Payment Arrangement, Expense $23,800,000 +27%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY